1Settimana·

New position

I believe in $MRK (-2,01%) even after Keytruda...


With the high R&D, I think things will continue positively

25.03
Merck & Co logo
Acquistato x25 a 81,30 €
2032,50 €
9
5 Commenti

immagine del profilo
Considering a savings plan at $MRK. Basically, of course, currently favorable in terms of P/E ratio, but the pipeline is really bad. Today I spent another 2 billion on a Chinese company... I don't have the faith for a high one-off amount at the moment.
2
immagine del profilo
1Settimana
@Michey777 if there is strong positive news again, the share price will no longer be so favorable...
1
immagine del profilo
@Puki may be. But does it apply to every share? In the end, we are now at around the level of the end of 2019...
immagine del profilo
I'm also torn as to whether I should buy more 🤔
immagine del profilo
1Settimana
Gardasil is the problem child, but 30 Phase III and 50 Phase II projects and a 3% dividend speak in favor of buying it
1
Partecipa alla conversazione